International Medical Services
Übersicht ausgewählter Publikationen
- The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marinò M, Vaidya B, Wiersinga WM; EUGOGO †. Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479. PMID: 34297684
- Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials. Kahaly GJ, Douglas RS, Holt RJ, Sile S, Smith TJ. Lancet Diabetes Endocrinol. 2021 Jun;9(6):360-372. doi: 10.1016/S2213-8587(21)00056-5. Epub 2021 Apr 15. PMID: 33865501
- Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease. Kahaly GJ, Diana T, Kanitz M, Frommer L, Olivo PD. J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1006-14. doi: 10.1210/clinem/dgz292. PMID: 31865369
- TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY. Kahaly GJ, Diana T, Olivo PD. Endocr Pract. 2020 Jan;26(1):97-106. doi: 10.4158/EP-2019-0363. PMID: 32022598
- High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease. Kahaly GJ, Wüster C, Olivo PD, Diana T., J Clin Endocrinol Metab. 2019 Jul 1;104(7): 2561-2568. doi: 10.1210/jc.2018-02705, PMID: 30753531
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, et al., Lancet Diabetes Endocrinol. 2018 Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2. Epub 2018 Jan 31., PMID: 29396246
- United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin. Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S, König J, Lupo MA, Raue F, Ringel MD, Sipos JA, Kratzsch J., Clin Chem. 2017 Sep;63(9):1489-1496. doi: 10.1373/clinchem.2016.270009. Epub 2017 Jul 7. PMID: 28687633
- Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation. Allelein S, Diana T, Ehlers M, Kanitz M, Hermsen D, Schott M, Kahaly GJ. Horm Metab Res. 2019 Jun;51(6):341-346. doi: 10.1055/a-0914-0535. Epub 2019 Jun 17. PMID: 31207654
- Teprotumumab for Thyroid-Associated Ophthalmopathy. Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS., N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. PMID: 28467880
- Graves’ Disease. Kahaly GJ, Olivo PD., N Engl J Med. 2017 Jan 12;376(2):184. PMID: 28079341
- Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies. Diana T, Wüster C, Kanitz M, Kahaly GJ.J Endocrinol Invest. 2016 Oct;39(10):1159-65. doi: 10.1007/s40618-016-0478-9. Epub 2016 May 19.PMID: 27197966